Aptose to Present at the Bloom Burton & Co. Healthcare Investor Conference 2018 Apr 24, 2018 7:00am EDT
OHSU and Aptose Present New CG’806 Preclinical Data at 2018 AACR Annual Meeting Apr 16, 2018 7:30am EDT
Aptose Presents New Preclinical Data on CG’806 Pan-FLT3/ Pan-BTK Inhibitor at 2018 AACR Annual Meeting Apr 16, 2018 7:30am EDT
Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference Apr 03, 2018 8:00am EDT
Aptose Reports Results for the Fourth Quarter and Year Ended December 31, 2017 Mar 27, 2018 4:15pm EDT
Aptose to Present New CG’806 and APTO-253 Data at the 2018 AACR Annual Meeting Mar 15, 2018 7:05am EDT
Aptose To Release Fourth Quarter and Year End December 31, 2017 Financial Results and Hold Conference Call on March 27, 2018 Mar 08, 2018 7:00am EST
Aptose Biosciences Announces Exclusive License Agreement for Dual BET/Kinase Targeting Program With OHM Oncology Mar 07, 2018 7:00am EST
